ATE477814T1 - Stabile faktor-viii enthaltende pharmazeutische zusammensetzung - Google Patents
Stabile faktor-viii enthaltende pharmazeutische zusammensetzungInfo
- Publication number
- ATE477814T1 ATE477814T1 AT03712418T AT03712418T ATE477814T1 AT E477814 T1 ATE477814 T1 AT E477814T1 AT 03712418 T AT03712418 T AT 03712418T AT 03712418 T AT03712418 T AT 03712418T AT E477814 T1 ATE477814 T1 AT E477814T1
- Authority
- AT
- Austria
- Prior art keywords
- viii
- pharmaceutical composition
- composition containing
- containing stable
- stable factor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0207092.8A GB0207092D0 (en) | 2002-03-26 | 2002-03-26 | Stable pharmaceutical composition containing factor VIII |
| PCT/GB2003/001297 WO2003080108A1 (en) | 2002-03-26 | 2003-03-26 | Stable pharmaceutical composition containing factor viii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE477814T1 true ATE477814T1 (de) | 2010-09-15 |
Family
ID=9933726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03712418T ATE477814T1 (de) | 2002-03-26 | 2003-03-26 | Stabile faktor-viii enthaltende pharmazeutische zusammensetzung |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7790680B2 (de) |
| EP (2) | EP1490095B1 (de) |
| JP (4) | JP2005530714A (de) |
| KR (1) | KR20040093482A (de) |
| CN (2) | CN103006540B (de) |
| AR (1) | AR039123A1 (de) |
| AT (1) | ATE477814T1 (de) |
| AU (1) | AU2003217030B2 (de) |
| BR (1) | BR0308442A (de) |
| CA (1) | CA2480226C (de) |
| DE (1) | DE60333825D1 (de) |
| DK (1) | DK1490095T3 (de) |
| ES (1) | ES2350337T3 (de) |
| GB (1) | GB0207092D0 (de) |
| HK (2) | HK1080713A1 (de) |
| HR (1) | HRP20040882B1 (de) |
| IL (2) | IL163849A0 (de) |
| IS (1) | IS7458A (de) |
| MX (1) | MXPA04009275A (de) |
| MY (1) | MY149831A (de) |
| NO (1) | NO328450B1 (de) |
| NZ (1) | NZ535032A (de) |
| PL (1) | PL208009B1 (de) |
| PT (1) | PT1490095E (de) |
| RU (1) | RU2314825C2 (de) |
| TW (1) | TWI285106B (de) |
| WO (1) | WO2003080108A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7560107B2 (en) | 1996-06-26 | 2009-07-14 | Emory University | Modified factor VIII |
| PL376219A1 (en) * | 2002-10-29 | 2005-12-27 | Alza Corporation | Stabilized, solid-state polypeptide particles |
| US7485291B2 (en) | 2003-06-03 | 2009-02-03 | Cell Genesys, Inc. | Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof |
| US7498024B2 (en) | 2003-06-03 | 2009-03-03 | Cell Genesys, Inc. | Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| JP2007534633A (ja) * | 2003-11-10 | 2007-11-29 | アライバ−プロメティック インコーポレイティド | ヒト・アルファ１−抗トリプシン製剤 |
| PL1750733T3 (pl) | 2004-05-03 | 2014-05-30 | Univ Emory | Sposób podawania świńskiego czynnika krzepnięcia VIII pozbawionego domeny B |
| WO2009130181A2 (en) * | 2008-04-21 | 2009-10-29 | Novo Nordisk Health Care Ag | Dry transglutaminase composition |
| EP2113564A1 (de) | 2008-05-01 | 2009-11-04 | Arecor Limited | Proteinformulierung |
| MX2011001624A (es) | 2008-08-21 | 2011-03-28 | Octapharma Ag | Factor viii y ix humano producido en forma recombinante. |
| RU2510279C3 (ru) * | 2008-09-03 | 2017-04-17 | Октафарма Аг | Новые защитные композиции для рекомбинантного фактора viii |
| JP5779780B2 (ja) * | 2008-11-07 | 2015-09-16 | バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ | 第ｖｉｉｉ因子製剤 |
| GB0915480D0 (en) * | 2009-09-04 | 2009-10-07 | Arecor Ltd | Stable formulation of factor viii |
| CA2816575C (en) | 2010-11-05 | 2019-06-11 | Baxter Healthcare S.A. | A new variant of antihemophilic factor viii having increased specific activity |
| SG10201803999UA (en) * | 2013-03-15 | 2018-06-28 | Bayer Healthcare Llc | Recombinant factor viii formulations |
| SG11201505924TA (en) | 2013-03-15 | 2015-09-29 | Biogen Ma Inc | Factor viii polypeptide formulations |
| PL3177317T3 (pl) | 2014-08-04 | 2020-07-27 | Csl Limited | Formulacja czynnika viii |
| WO2016080367A1 (ja) * | 2014-11-18 | 2016-05-26 | 塩野義製薬株式会社 | 安定化されたペプチド組成物 |
| WO2021001522A1 (en) | 2019-07-04 | 2021-01-07 | CSL Behring Lengnau AG | A truncated von willebrand factor (vwf) for increasing the in vitro stability of coagulation factor viii |
| CN116322920A (zh) | 2020-11-09 | 2023-06-23 | 武田药品工业株式会社 | 使用氧化硅吸附从血浆中纯化fviii |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6281327A (ja) * | 1985-10-04 | 1987-04-14 | Green Cross Corp:The | 人トロンビン製剤の加熱処理方法 |
| JPS6485927A (en) | 1987-09-29 | 1989-03-30 | Green Cross Corp | Hepatitis b vaccine |
| US5605884A (en) | 1987-10-29 | 1997-02-25 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Factor VIII formulations in high ionic strength media |
| WO1989009784A1 (en) * | 1988-04-08 | 1989-10-19 | Commonwealth Serum Laboratories Commission | Production of heat-stable factor viii concentrate |
| SE465222C5 (sv) | 1989-12-15 | 1998-02-10 | Pharmacia & Upjohn Ab | Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning |
| IE64738B1 (en) * | 1990-03-20 | 1995-09-06 | Akzo Nv | Stabilized gonadotropin containing preparations |
| DE4111393A1 (de) * | 1991-04-09 | 1992-10-15 | Behringwerke Ag | Stabilisierte faktor viii-praeparationen |
| DE69329795T2 (de) | 1992-10-02 | 2001-07-05 | Genetics Inst | Zusammensetzung, welche den koagulationsfaktor viii beinhaltet; verfahren zu deren herstellung und die benutzung eines oberflächenaktiven stoffes als stabilisator |
| SE9301581D0 (sv) | 1993-05-07 | 1993-05-07 | Kabi Pharmacia Ab | Protein formulation |
| SE504074C2 (sv) | 1993-07-05 | 1996-11-04 | Pharmacia Ab | Proteinberedning för subkutan, intramuskulär eller intradermal administrering |
| ZA955642B (en) * | 1994-07-07 | 1997-05-06 | Ortho Pharma Corp | Lyophilized imaging agent formulation |
| JPH0899999A (ja) | 1994-09-30 | 1996-04-16 | Chemo Sero Therapeut Res Inst | α１プロテアーゼインヒビターの製造方法 |
| US6458563B1 (en) * | 1996-06-26 | 2002-10-01 | Emory University | Modified factor VIII |
| US5763401A (en) | 1996-07-12 | 1998-06-09 | Bayer Corporation | Stabilized albumin-free recombinant factor VIII preparation having a low sugar content |
| BR0008405B1 (pt) * | 1999-02-22 | 2014-04-22 | Baxter Int | Composição de fator viii formulada sem a adição de albumina, uso de uma composição de fator viii, e, método de liofilizar uma formulação farmacêutica aquosa |
| AU780415B2 (en) * | 1999-07-13 | 2005-03-17 | Biovitrum Ab | Stable Factor VIII compositions |
| AU6558400A (en) * | 1999-08-17 | 2001-03-13 | Novo Nordisk A/S | Stabilisation of freeze-dried cake |
| US6586574B1 (en) * | 1999-08-17 | 2003-07-01 | Nn A/S | Stabilization of freeze-dried cake |
| US7282562B2 (en) * | 1999-08-31 | 2007-10-16 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
-
2002
- 2002-03-26 GB GBGB0207092.8A patent/GB0207092D0/en not_active Ceased
-
2003
- 2003-03-14 TW TW092105665A patent/TWI285106B/zh not_active IP Right Cessation
- 2003-03-19 MY MYPI20030960A patent/MY149831A/en unknown
- 2003-03-25 AR ARP030101024A patent/AR039123A1/es not_active Application Discontinuation
- 2003-03-26 PT PT03712418T patent/PT1490095E/pt unknown
- 2003-03-26 CN CN201210563117.1A patent/CN103006540B/zh not_active Expired - Lifetime
- 2003-03-26 ES ES03712418T patent/ES2350337T3/es not_active Expired - Lifetime
- 2003-03-26 US US10/507,956 patent/US7790680B2/en not_active Expired - Lifetime
- 2003-03-26 RU RU2004131556/15A patent/RU2314825C2/ru active
- 2003-03-26 JP JP2003577934A patent/JP2005530714A/ja active Pending
- 2003-03-26 IL IL16384903A patent/IL163849A0/xx unknown
- 2003-03-26 BR BR0308442-6A patent/BR0308442A/pt not_active Application Discontinuation
- 2003-03-26 EP EP03712418A patent/EP1490095B1/de not_active Expired - Lifetime
- 2003-03-26 DK DK03712418.7T patent/DK1490095T3/da active
- 2003-03-26 PL PL372414A patent/PL208009B1/pl unknown
- 2003-03-26 AU AU2003217030A patent/AU2003217030B2/en not_active Expired
- 2003-03-26 AT AT03712418T patent/ATE477814T1/de active
- 2003-03-26 KR KR10-2004-7015295A patent/KR20040093482A/ko active Search and Examination
- 2003-03-26 MX MXPA04009275A patent/MXPA04009275A/es active IP Right Grant
- 2003-03-26 EP EP10172869A patent/EP2292216A3/de not_active Withdrawn
- 2003-03-26 DE DE60333825T patent/DE60333825D1/de not_active Expired - Lifetime
- 2003-03-26 NZ NZ535032A patent/NZ535032A/xx not_active IP Right Cessation
- 2003-03-26 CN CN038069911A patent/CN1642570B/zh not_active Expired - Lifetime
- 2003-03-26 WO PCT/GB2003/001297 patent/WO2003080108A1/en active Application Filing
- 2003-03-26 CA CA2480226A patent/CA2480226C/en not_active Expired - Lifetime
-
2004
- 2004-08-31 IL IL163849A patent/IL163849A/en not_active IP Right Cessation
- 2004-09-17 IS IS7458A patent/IS7458A/is unknown
- 2004-09-24 HR HRP20040882AA patent/HRP20040882B1/hr not_active IP Right Cessation
- 2004-10-11 NO NO20044305A patent/NO328450B1/no not_active IP Right Cessation
-
2006
- 2006-01-13 HK HK06100540.9A patent/HK1080713A1/xx not_active IP Right Cessation
-
2011
- 2011-01-07 JP JP2011002185A patent/JP2011079862A/ja active Pending
-
2013
- 2013-04-16 JP JP2013085801A patent/JP5770775B2/ja not_active Expired - Lifetime
- 2013-09-24 HK HK13110894.1A patent/HK1183446A1/xx not_active IP Right Cessation
-
2015
- 2015-03-18 JP JP2015055071A patent/JP2015143245A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE334656T1 (de) | Flüssige pharmazeutische zusammensetzung | |
| ATE307571T1 (de) | Pharmazeutische formulierung enthaltend bicalutamid | |
| ATE355271T1 (de) | Pharmazeutische zusammensetzung | |
| AT7729U3 (de) | Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat | |
| PT1501534E (pt) | Formulacoes farmaceuticas | |
| FI20011478A (fi) | Farmaseuttinen koostumus | |
| ATE407663T1 (de) | Azithromycin enthaltende pharmazeutische zusammensetzungen mit verringerten nebenwirkungen | |
| ATE317260T1 (de) | Pharmazeutische formulierungen mit platinderivaten | |
| ATE477814T1 (de) | Stabile faktor-viii enthaltende pharmazeutische zusammensetzung | |
| DE60315939D1 (de) | Pharmazeutische zusammensetzung enthaltend ein androgen | |
| DE60312049D1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff | |
| DE602004016967D1 (de) | Flüssige pharmazeutische palonosetronformulierungen | |
| PT1467724E (pt) | Composicao farmaceutica orodispersavel de agomelatina | |
| ATE320807T1 (de) | Pharmazeutische zusammensetzungen enthaltend tegaserod | |
| DK1587478T3 (da) | Farmaceutisk sammensætning | |
| DE60211183D1 (de) | Pharmazeutische zusammensetzung enthaltend lumiracoxib | |
| ATE327759T1 (de) | Pharmazeutische zusammensetzung mit verlungerter freisetzung | |
| ATE350016T1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
| FI20022128A (fi) | Farmaseuttinen koostumus | |
| DE60129238D1 (de) | Pharmazeutische zusammensetzung | |
| ATE507831T1 (de) | Melatonin enthaltende pharmazeutische formulierung | |
| DE10291905D2 (de) | Pharmazeutische Zusammensetzung | |
| ATE350029T1 (de) | Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain | |
| ATE330623T1 (de) | Stabile pharmazeutische zusammensetzung mit erythropoietin | |
| DE10107261B4 (de) | Pharmazeutische Zusammensetzung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1490095 Country of ref document: EP |